Jump to content

20250179137. Il18 Receptor (Regeneron Pharmaceuticals, .)

From WikiPatents

IL18 RECEPTOR AGONISTS AND METHODS OF USE THEREOF

Abstract: the present disclosure relates to il18 receptor agonists with improved therapeutic profiles.

Inventor(s): Jiaxi WU, Aaron CHANG, Olivia ANTAO, Eva-Maria WEICK, Amanda DORVILLIERS, Erica ULLMAN

CPC Classification: C07K14/54 (PEPTIDES (peptides in foodstuffs ; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs ; preparations for medicinal purposes ; peptides containing beta-lactam rings ; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, ; ergot alkaloids of the cyclic peptide type ; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids ; macromolecular products derived from proteins ; preparation of glue or gelatine ; single cell proteins, enzymes ; genetic engineering processes for obtaining peptides ; compositions for measuring or testing processes involving enzymes ; investigation or analysis of biological material ))

Search for rejections for patent application number 20250179137


Cookies help us deliver our services. By using our services, you agree to our use of cookies.